Drug intelligence / Profile preview

Gyneffik

Development stage
Unknown
Lead developer
Effik
Modality
Live Biotherapeutic Products → Microbiome Therapeutics
Administration
Vaginal
01

Overview

Gyneffik is a vaginal probiotic treatment developed and marketed by Effik, specifically designed to restore and maintain a healthy vaginal microbiota. The product contains a high concentration of the specific probiotic strain *Lactobacillus plantarum* P 17630. This strain is characterized by its strong capacity to adhere to the vaginal mucosa, where it forms a protective biological barrier. By colonizing the vaginal environment, these lactobacilli produce lactic acid, which helps maintain the physiological acidic pH (around 4.5) necessary to inhibit the growth and attachment of pathogenic microorganisms such as *Candida albicans* and *Gardnerella vaginalis*. Gyneffik is typically indicated for the prevention of recurrent vaginal infections, such as bacterial vaginosis and vulvovaginal candidiasis, often following a course of antibiotic or antifungal therapy.

Brand names
Gyneffik
Other names
Lactobacillus plantarum P 17630

Beyond the preview

Go deeper on Gyneffik.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gyneffik.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call